534796 A7 --- ___ _B7_ 五、發明説明（j 產業上之利用領域 (請先閲讀背面之注意事項再填寫本頁) 本發明是關於，在常溫下能使藥劑揮散之藥劑揮散裝 置。詳細而言’回轉存放藥劑含浸體且與翼部一體成形之 藥劑匣’利用回轉所產生的氣流，促進該藥劑含浸體，可 以一定之揮散速度，長時間連續揮散藥劑之藥劑揮散裝 置。 先行技術 爲驅除害蟲，如蚊、蚋等，以藥劑揮散裝置揮散放出 藥劑，充滿整個密閉空間（如：建築物或車內、帳棚 內）。如利用熱能使蚊香、電蚊香、電蚊香液等藥劑揮散 裝置。這種藥劑揮散裝置，一般是以直火或電能爲熱能來 源，爲確保安全性或產生足夠之熱能裝置，有時會難以利 用。例如，對於在帳棚內等使用直火之危險性且無電源之 狀況，以在常溫下使用，可足夠揮散放出藥劑之裝置爲 宜。 經濟部智慧財產局員工消費合作社印製 在以往，就已有不使用熱能且能在常溫揮散放出藥劑 之裝置之提案，特別是在常溫下，利用風扇等風力，與只 放置藥劑（或藥劑含浸體）自然揮散之效果相比較，可期 待藥劑之揮散效率大幅向上。 特開平1 0 - 1 9 1 8 6 2號中說明，將粒狀之藥劑 含浸體收放於靜止之含浸體容器中，以風扇之風力攪拌， 而揮散出藥劑之裝置。 然而，此裝置中，藥劑含浸體與風扇相分開，吹向藥 本紙張尺度適用中國國家標準（CNS ) A4規格（210X 297公釐） -4 - 534796 A7 B7 五、發明説明（j (請先閱讀背面之注意事項再填寫本頁) 劑含浸體只是微風。這就是此裝置爲何難以長時間且一定 揮散量將藥劑揮散，隨時間經過揮散藥量也隨之減少的原 因。 關於特開平5 - 6 8 4 5 9號中裝置的說明，封入揮 散性藥劑於具通氣性之薄膜或是具有微小孔而得透氣之袋 子或容器中爲擴散用材。回轉此擴散用材，使揮散性藥劑 於空氣中擴散。然而，此法中使用之擴散用材，很難使整 個揮散性藥劑有效地揮散出來。因此無法避免藥劑之揮散 量隨時間經過而減少。 發明所欲解決之問題 本發明是以解決如上述關於先行技術下藥劑揮散裝置 的問題爲目的。本發明提供，不使用熱能且經過長時間， 如1 0天以上仍可穩定地揮散藥劑，進而可防止經時性的 揮散量減少、可適於戶外使用、持續性優異的殺菌效果、 安全性高及良好的使用性等多項優點之藥劑揮散裝置。 經濟部智慧財產局8工消費合作社印製 解決問題之方法 本發明者等，爲解決上述課題努力硏究之結果，發現 與翼部一體成形可收放藥劑含浸體之環狀中空構造體，回 轉此中空構造體，產生由內部至外部之氣流，促進藥劑揮 散，經過長時間（如1天1 2小時，期間3 0天）能得到 穩定之揮散性能，因而完成了本發明。 本發明是關於藥劑揮散裝置，其特徵爲，形成凹形部 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） -5- 534796 A7 B7 五、發明説明（ 可收放 劑匣， 置本體 蓋在凹 環狀中 空構造 中空構 面向其 圓面之 藥劑匣之裝 與藥劑匣之 之驅動方法 形部之藥劑 空構造體， 體的中心位 造體以複數 中心延伸， 氣流通過之 置本體，受凹形部支持可自由回轉之藥 旋轉支持軸連接之馬達爲電源，是此裝 ’並備有盍子安裝在本裝置本體，可覆 匣上。收放粒狀藥劑含浸體之藥劑匣爲 內外圓面均各有開口部，軸心部位於中 置’連接上述之回轉支持軸，軸心部及 輪輻部相連接’使該中空構造體由內圓 並與促進由該中空構造體之內圓面至外 翼部形成一體。 I ^------衣-- (請先閱讀背面之注意事項再填寫本頁} 經濟部智慧財產局員工消費合作社印製 列舉本發明中令人滿意之狀態 (a ) 關於上述之藥劑揮散 本體部份及蓋子部份所形成； (b ) 關於上述之藥劑揮散 狀及具有許多細隙所形成； (c ) 關於上述之藥劑揮散 彎曲，其長度至少5mm以上； (d ) 關於上述之藥劑揮散 外徑平均3mm至1 〇mm，爲開 (e ) 關於上述之藥劑揮散 藥劑含浸體，其空隙率爲2 0 %至 (f )上述之藥劑揮散裝置中 (I )所示，含有氟素置換基之苯 合物； 如下。 裝置中，中空構造體爲 裝置中，開口部爲平行 裝置中，翼部成弧狀或 裝置中，藥劑含浸體之 口部尺寸之1 . 3倍； 裝置中，藥劑匣可收放 7 0%； ，藥劑含浸體如一般式 甲醇酯化合物或是其混 、11534796 A7 --- ___ _B7_ V. Description of the invention (j. Fields of application in industry (please read the notes on the back before filling out this page) The present invention relates to a medicament volatilization device capable of volatilizing medicaments at normal temperature. Say 'the medicine box which stores the medicine impregnated body in a rotating manner and is integrally formed with the wing part' uses the air flow generated by the rotation to promote the medicine impregnated body, which can continuously disperse the medicine for a long time with a certain volatilization speed. Pests, such as mosquitoes, maggots, etc., release the medicine with a medicine spraying device, filling the entire enclosed space (such as in a building or a car, in a tent). .This kind of medicine dispersing device usually uses direct fire or electric energy as the heat energy source. In order to ensure safety or generate sufficient thermal energy, it may be difficult to use. For example, the danger of using direct fire in tents and the like and In the case of no power supply, it is advisable to use the device at room temperature, which can sufficiently disperse and release the medicine. In the past, the printing company has proposed a device that does not use thermal energy and can emit medicine at room temperature. In particular, at room temperature, the effect of using the wind such as a fan to naturally disperse the medicine (or the medicine impregnated body) is used. By comparison, it can be expected that the volatilization efficiency of the medicine will be greatly improved. JP-A-Hei 10-1 9 1 8 6 2 explains that the granular medicine impregnated body is stored in a stationary impregnated body container and stirred by the wind of a fan. However, in this device, the medicine impregnated body is separated from the fan, and the paper size is applied to the Chinese paper (CNS) A4 specification (210X 297 mm) -4-534796 A7 B7 V. Description of the invention (j (please read the precautions on the back before filling this page) The agent impregnated body is only a breeze. This is why this device is difficult to disperse the medicine for a long time and a certain amount of volatilization, and the amount of volatilization decreases with time. For the explanation of the device in JP-A-Heisei 5-6 8 4 5 9, the volatile medicine is sealed in a breathable film or a bag or container with micro holes for ventilation. Material. Turn this diffusion material to diffuse the volatile medicine in the air. However, the diffusion material used in this method makes it difficult to effectively diffuse the entire volatile medicine. Therefore, it is impossible to prevent the amount of volatile medicine from decreasing over time. The problem to be solved by the invention The present invention aims to solve the above-mentioned problem about the medicine dispersing device under the prior art. The invention provides that the medicine can be stably dispensed without using heat energy for a long time, such as more than 10 days, Furthermore, it is a pharmaceutical dispersion device that can prevent volatile emissions over time, can be suitable for outdoor use, has excellent sterilization effects, high safety and good usability, etc. Printed by the Ministry of Economic Affairs, Intellectual Property Bureau As a result of intensive research to solve the above-mentioned problems, the inventors of the present invention found that a ring-shaped hollow structure capable of storing and storing a drug-impregnated body is formed integrally with the wing, and the hollow structure is rotated to generate the inside to the outside. The air flow promotes the dispersion of the medicine, and can be stabilized after a long period of time (such as 1 day, 12 hours, and 30 days). The vaporized properties, thus completing the present invention. The invention relates to a medicament dispersing device, which is characterized in that a concave portion is formed and the paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) -5- 534796 A7 B7 5. Description of the invention The body is covered with a hollow annular hollow structure. The hollow structure faces the round surface of the medicine box and the method of driving the medicine box. The medicine empty structure is formed at the center of the body. The body extends at a plurality of centers, and the airflow passes through it. The main body is supported by a motor that is connected to the medicine rotation support shaft supported by the concave part and is a power source. It is equipped with a dumpling and is mounted on the body of the device and can be covered on the box. The box is provided with openings on both the inner and outer circular surfaces, and the shaft center portion is located at the center. 'The above-mentioned rotary support shaft is connected, and the shaft center portion and the spoke portion are connected.' The hollow structure is formed from the inner circle and promotes the hollow structure. The inner circular surface and the outer wing are integrated. I ^ ------ 衣-(Please read the notes on the back before filling out this page} Printed by the Consumers ’Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs people The intended state (a) is about the formation of the above-mentioned medicament volatilization body part and the cover part; (b) is about the above-mentioned medicament volatilization and is formed with many fine gaps; (c) about the above-mentioned medicament volatility bending, its length At least 5mm or more; (d) The average outside diameter of the above-mentioned drug dispersion is 3mm to 10mm, which is on. (E) About the above-mentioned drug dispersion, the impregnated body has a void ratio of 20% to (f) the above-mentioned drug dispersion. As shown in (I) in the device, a benzene compound containing a fluorine-substituted group is as follows: In the device, the hollow structure is in the device, the opening is in a parallel device, the wings are arc-shaped, or the device is impregnated with the agent. 1.3 times the size of the mouth; In the device, the medicine box can be retracted by 70%; the impregnated body of the medicine such as a general methyl ester compound or a mixture thereof, 11
- i s I 7 534796 A7 B7 五、發明説明（j-i s I 7 534796 A7 B7 V. Description of the invention (j
(請先閲讀背面之注意事項再填寫本頁) (式中，X及Y爲相同或不同之氫原子、甲基、鹵素 原子或三氟甲基；Z爲氫原子、氟原子、甲基、甲氧基或 炔丙基。） (g )上述之藥劑揮散裝置中，藥劑含浸體可含有以 下之藥劑或其混合物，2，3，5，6 -四氟苯甲基一除 蟲菊酸、2，3，5，6 —四氟苯曱基一 2，2 —二甲基 —3— (1 -丙烯基）環丙烷羧酸、4 一甲基一 2，3， 5，6 —四氟苯甲基一除蟲菊酸、4 —甲基一2，3， 經濟部智慧財產局員工消費合作社印製 5，6 —四氟苯甲基一2，2 —二曱基一3 — (2，2 — —^氯乙矯基）環丙院竣酸、4 一甲基—2，3，5，6 -四氣本甲基一 2 ’ 2 — —^甲基一3— (2，2 —二氣乙傭 基）環丙烷羧酸、4 一甲氧基甲基—2，3，5，6 —四 氟苯甲基一除蟲菊酸、4 一甲氧基甲基一 2，3，5，6 —四氟苯甲基—2，2 -二甲基一 3—（1—丙烯基）環 丙烷羧酸、2，3，4，5，6 -五氟苯甲基一 2，2 — 二甲基一3—(2-氯一2-三氟甲基乙烯基）環丙烷羧 酸、4 —诀丙基—2，3，5，6 —四氟苯甲基一 3 — (1—丙烯基）一 2，2 -二甲基環丙院竣酸、4 一甲氧 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） 534796 A7 B7 五、發明説明（p 基甲基—2，3，5，6 —四氟苯甲基—2，2，3，3 四甲基環丙院竣酸以及4〜炔丙基—2，3，5，6 - 四氟苯甲基—2，2，3，3 —四甲基環丙烷羧酸； (h )上述之藥劑揮散裝置中，藥劑含浸體含有上述 藥劑6 0 m g以上； (i )上述之藥劑揮散裝置中，藥劑含浸體是以紙、 紙漿、纖維素系載體或是合成樹脂載體、或是其混合物爲 基材； (j )上述之藥劑揮散裝置中，馬達之回轉數爲 500 至 2000rpm; (k )上述之藥劑揮散裝置中，以每小時藥劑揮散量 〇 · 0 1至0 _ 6 m g且持續1 8 0小時以上之藥劑含浸 體所構成； (1 )上述之藥劑揮散裝置中，由聚酯樹脂所形成之 藥劑匣； (m )上述之藥劑揮散裝置中，聚酯樹脂爲聚對苯二 甲酸乙二醇酯（polyethylene terephthalate); (η ) 上述之藥劑揮散裝置中，聚對苯二甲醇乙二 醇酯之粘度限制爲0 . 7 d 1 / g以下； (〇 ) 上述之藥劑揮散裝置中，更具備有可目測藥 劑殘量功能之液晶顯示器； (p ) 上述之藥劑揮散裝置中，顯示藥劑殘量功 能，可對應多種有效時間不同之藥劑匣。在藥劑匣之對面 設置磁氣感應掃描器或光掃描器，以感應安裝在藥劑匣之 本紙張尺度適用中國國家標準（CNS ) A4規格（21〇x297公釐） (請先閲讀背面之注意事項再填寫本頁) i0^. 訂 經濟部智慧財產局K工消費合作社印製 -8 - 534796 A7 B7 五、發明説明（d 磁氣帶或金屬器材所發出之信號。而中央處理裝置接收上 述掃描器感應到之傳達信號，而辨別出藥劑匣之種類； (請先閲讀背面之注意事項再填寫本頁) (Q ) 上述之藥劑揮散裝置中，內藏電路伴隨馬達 運作時發出固有的電波信號，中央處理裝置以感應到的電 波is號測疋馬達運作時間’並控制藥劑殘量顯示； (r ) 上述之藥劑揮散裝置中，更具備有可目測電 池殘量功能之液晶顯示器； (s ) 上述之藥劑揮散裝置中，顯示電池殘量功 能，由顯示部、電壓低下判別電路以及辨識電池電壓且控 制電池殘量顯示之中央處理裝置所構成。 經濟部智慧財產局g(工消費合作社印製 本發明中之藥劑揮散裝置，其特徵爲，使用與翼部形 成一體之環狀中空構造體爲藥劑匣。翼部與環狀中空構造 體一體成形之本發明之藥劑匣，與分開製作組成之比較例 相比較，後者需要支持各翼部之環狀支持部（類似中空構 造體之內圓面之構造物），而本發明之藥劑匣則無此需 要。因此，本發明之藥劑匣可使翼部的長度加長，產生更 強的氣流與藥劑接觸，且不會因翼部的關係使氣流變弱。 因此得知，產生氣流的翼部與中空構造體一體化後，可幫 助提升揮散效率。另外，從生產觀點而言，翼部與中空構 造體一體化後，無二者分別製造後再組合之必要。特別是 個別製造之翼部，安裝於中空構造體時，必須注意翼部不 可塞住中空構造體內圓面之開口部，使組合時變得很麻 煩。中空構造體與翼部成一體化時，在設計的階段時，翼 部設計在非開口部之位置，而不阻塞中空構造體內圓面之 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） -9- 534796 Α7 Β7 五、發明説明（9 開口部，使生產量大幅提升。 發明之實施形態 本發明中之藥劑揮散裝置，以驅動方式使收放藥劑含 浸體之藥劑匣回轉，因離心力漸漸使藥劑含浸體產生作 用，在常溫中揮散藥劑。使藥劑含浸體產生作用之離心 力，達到如以下之種種效果，對藥劑經長時間使用仍能穩 定揮散有所貢獻。 1 )藥劑含浸體事先以良好狀態收放在藥劑匣.中。然 而，個個的藥劑含浸體並未被固定住，在藥劑匣受衝撃移 動時，藥劑含浸體也隨之移動，收放狀態亦隨之改變。但 於使用時，離心力作用於藥劑含浸體，將之擠壓至藥劑匣 之外圓面側，再度恢復成良好之收放狀態。 2 )隨著離心力作用之解除，個個的藥劑含浸體也隨 藥劑匣之回轉或移動有某些程度的移動，改變了位置。因 此隨著離心力於藥劑匣作用解除後，也移動了藥劑含浸 體，也就達到了攪拌的效果。 3 )離心力作用於藥劑含浸體，使藥劑含浸體內部之 藥劑因離心力而擠出表面，且隨藥劑匣之回轉產生氣流而 促進蒸散，因此藥劑含浸體內部之藥劑能有效地被蒸散出 來。 上述之離心力大小由藥劑匣之回轉狀態決定。例如， 離心力之大小爲1 / 1 0 0 0〜1 0 0倍之重力加速度 (9.8xl02cm/s2)，即 9 . 8χ ΙΟ — ^ιη/ 本紙張尺度適用中國國家標準（CNS ) A4規格（21〇X297公釐） Ί — J-------^^衣-- (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部智慧財產局員工消費合作社印製 -10- 534796 A7 B7 五、發明説明（g s2〜9 · 8x 104cm/s2。 本發明之藥劑揮散裝置中，藥劑匣爲收放藥劑含浸體 而形成有中空部之環狀中空構造體。爲能得到希望之揮散 量，該中空構造體之大小，可隨應放入藥劑含浸體的量而 改變。藥劑匣可任意形狀，如中空構造體之斷面可爲長方 形。 對於中空構造體之製作，及內部可收放藥劑含浸體等 而言，上述之中空構造體由具環狀溝槽之本體部份與溝槽 蓋所構成是非常理想的。 本發明中，構成藥劑匣之環狀中空構造體，其內外圓 面均有開口部，爲揮散藥散藥劑作用之通氣孔。爲得到足 夠之通氣性，可任意設計開口部，但開口部總面積與藥劑 匣圓面總面積之比率，以設定在1 : 1 〇至1 : 2爲宜。 開口部之形狀，可爲開口細隙或以吊環固定之細網所 構成。以多數平行狀之開口細隙爲宜。 另外，爲防止於使用前，由藥劑匣中藥劑含浸體揮散 出藥劑，藥劑匣之開口部以膠帶等遮蔽部材封住爲宜。由 於該遮蔽部材於使用時必須去除，以能簡單剝離之膠帶等 爲宜。 關於本發明之藥劑匣，在不阻塞環狀中空構造體內圓 面之開口部之位置，與向中空構造體中心延伸之翼部形成 一體。因此，該翼部具有隨藥劑匣之回轉，促進中空構造 體之內圓面向外圓面氣流通過之形狀。 上述翼部的長度並未有特別限制，但以5 m m爲宜。 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） 7--J------衣-- (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部智慧財產局員工消費合作社印製 -11 - 534796 A7 B7 五、發明説明（^ (請先閲讀背面之注意事項再填寫本頁) 可改變其形狀來調節回轉藥劑匣時所產生之氣流強弱。例 如翼部越長，所產生氣流越強。另外，翼部若成弧狀或彎 曲’就能送更多空氣至中空構造體之外圓面側。 上述構成藥劑匣之中空構造體之環狀中心，具有回轉 支持軸可連接使藥劑匣回轉之驅動部份，及連接支持軸之 軸心部。該軸心部是使藥劑匣與回轉支持軸緊密連接。例 如使用圓柱狀之材料，使回轉支持軸緊密結合。 上述軸心部是以複數輪輻部與中空構造體相連接。輪 輻部可爲任意支數，如2至4支，但以3或4支之輪輻部 使軸心部與中空構造體相連接爲宜。 本發明中，由加工性或使用性的觀點來看，以聚酯樹 脂製造爲宜。聚酯樹脂如聚對苯二甲酸乙二醇酯、聚對苯 二甲酸丁二醇酯、透明塑膠樹脂P A R、聚碳酸酯。其中 以聚對苯二甲酸乙二醇酯爲宜。 經濟部智慧財產局員工消費合作社印製 關於本發明中，上述之聚對苯二曱酸乙二醇酯之粘度 限制爲，苯酚/1，1，2，2 —四氯乙烷（重量比二1 / 1 )之混合溶媒中，在2 5 °C測定時以0 · 7 d 1 / g 以下爲宜。聚對苯二甲酸乙二醇酯之粘度限制在此範圍 時，本發明中之藥劑匣之強度及成形性會更好，在使用時 不會損失藥劑成份且能有效地慢慢地放出藥劑成份。另 外，在不損害本發明之特性之範圍下，可在上述之樹脂中 加入滑劑（如石鱲、脂肪族酯、脂肪族醇等）、安定劑 (如含有鈣、鋅化合物等）、衝撃強度補強劑、抗氧化 劑、紫外線吸收劑、耐候性改良劑、顏料、加工助劑或耐 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） -12- 534796 A7 B7 五、發明説明（）〇 熱改良劑等。 1—1—^---#! (請先閲讀背面之注意事項再填寫本頁) 本發明之藥劑揮散裝置中，所使用之藥劑含浸體之形 狀可有種種變化，如球狀、橢圓狀、蛋形、圓柱狀、角柱 狀、棒狀、圓板狀、角板狀、不定形等。 特別是以平均外徑3mm至1 〇mm，爲前述之開口 部之1 · 3倍之粒狀藥劑含浸體爲宜。採用如此尺寸及形 狀的藥劑含浸體時，其內部藥劑逐漸移至表面，可保持長 時間且穩定之揮散量。相反地，若藥劑含浸體之平均外徑 小於3 m m，藥劑過度快速揮散，造成殺菌效力是否能持 續之問題。 上述之藥劑含浸體於藥劑匣內之空隙率（未充塡藥劑 含浸體之空隙之內部容積比率％)爲2 0%至7 0%，以 2 5%至6 5%爲宜，尤以3 0%至6 0%爲佳。空隙率 未滿2 0 %時，空氣難以通過藥劑匣，未能確保足夠之藥 劑揮散量。相對地，空隙率超過7 0 %時。空氣與藥劑接 觸時間短，亦不能確保足夠之藥劑揮散量。 經濟部智慧財產局員工消費合作社印製 上述之藥劑含浸體所含之藥劑可調整爲每小時之揮散 量0 · 01至0 . 6mg，且有十.分殺蟲效果之藥劑爲 宜。此種藥劑特別以揮散性合成除蟲菊精類殺蟲劑爲例， 該韻殺蟲劑如一般式（I )所示，含有氟素置換基之苯醇 酯化合物。 本紙張尺度適用中國國家標準（CNS ) A4規格（21〇><297公釐） -13- 534796 A7 B7 五、發明説明（心(Please read the precautions on the back before filling this page) (where X and Y are the same or different hydrogen atom, methyl, halogen atom or trifluoromethyl; Z is hydrogen atom, fluorine atom, methyl, (Methoxy) or propargyl.) (G) In the above-mentioned medicament volatilization device, the medicament impregnated body may contain the following medicament or a mixture thereof, 2,3,5,6-tetrafluorobenzyl-pyethrin, 2,3,5,6-tetrafluorophenylfluorenyl-2,2-dimethyl-3- (1-propenyl) cyclopropanecarboxylic acid, 4 monomethyl-2,3,5,6-tetrafluoro Phenylmethyl pyrethroid, 4-methyl-2,3, printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs, 5,6-tetrafluorobenzyl-2,2-difluorenyl-3 — (2 , 2 — — ^ Chloroethenyl) ciprofen, 4-methyl-2,3,5,6-tetrakis-benzylmethyl 2 '2 — — ^ methyl-3 — (2,2 —Difluoroethenyl) cyclopropanecarboxylic acid, 4-monomethoxymethyl-2,3,5,6-tetrafluorobenzyl-pyrethrin, 4-methoxymethyl-2,3 , 5,6-tetrafluorobenzyl-2,2-dimethyl-3- (1-propenyl) cyclopropane Carboxylic acid, 2,3,4,5,6-pentafluorobenzyl-2,2-dimethyl-3- (2-chloro-2-trifluoromethylvinyl) cyclopropanecarboxylic acid, 4 — Propyl-2,3,5,6-tetrafluorobenzyl-1, 3- (1-propenyl) -2,2-dimethylcyclopropane, 4-methyloxy This paper is applicable to China Standard (CNS) A4 specification (210X297 mm) 534796 A7 B7 V. Description of the invention (p-methyl-2-2,3,5,6-tetrafluorobenzyl-2,2,3,3 tetramethylcyclopropane Hospital acid and 4 ~ propargyl-2,3,5,6-tetrafluorobenzyl-2,2,3,3-tetramethylcyclopropanecarboxylic acid; (h) in the above-mentioned pharmaceutical volatilization device, The drug impregnated body contains more than 60 mg of the above-mentioned drug; (i) in the above-mentioned drug volatilization device, the drug impregnated body is based on paper, pulp, cellulose-based carrier or synthetic resin carrier, or a mixture thereof; (j) ) In the above medicine dispersing device, the number of revolutions of the motor is 500 to 2000 rpm; (k) In the above medicine dispersing device, the amount of medicine dispersing per hour is 0. 0 to 0 -6 mg for more than 180 hours. Medicated impregnated body Composition; (1) In the above-mentioned medicament volatilization device, a medicament box formed of a polyester resin; (m) In the above-mentioned medicament volatilization device, the polyester resin is polyethylene terephthalate; (η) In the above-mentioned medicament volatilization device, the viscosity of polyethylene terephthalate is limited to 0.7 d 1 / g or less; (〇) In the above-mentioned medicament volatilization device, the remaining amount of the medicament can be visually inspected Functional liquid crystal display; (p) In the above-mentioned medicament dispersing device, the function of displaying the remaining amount of medicament can correspond to a variety of medicament cartridges with different effective times. A magnetic induction scanner or light scanner is installed on the opposite side of the medicine box to inductively install the paper size of the medicine box to the Chinese National Standard (CNS) A4 specification (21 × 297 mm) (Please read the precautions on the back first) (Fill in this page again) i0 ^. Order printed by K Industrial Consumer Cooperative of Intellectual Property Bureau of the Ministry of Economic Affairs-534 796 A7 B7 V. Description of the invention (d. Signal from magnetic tape or metal equipment. The central processing unit receives the above scan Distinguish the type of the medicine cassette by transmitting the signal sensed by the device; (Please read the precautions on the back before filling this page) (Q) In the above medicine dispersion device, the built-in circuit emits an inherent radio wave signal when the motor operates The central processing device measures the operating time of the motor with the sensed radio wave is and controls the display of the remaining amount of the medicine; (r) The above-mentioned medicine dispersing device has a liquid crystal display capable of visually detecting the remaining amount of the battery; (s) In the above medicine dispersing device, the function of displaying the remaining battery capacity is displayed by a display unit, a low-voltage determination circuit, and a center for identifying the battery voltage and controlling the display of the remaining battery capacity. The device is printed by the Intellectual Property Bureau of the Ministry of Economic Affairs (the Industrial and Consumer Cooperatives), which is characterized in that a ring-shaped hollow structure integral with the wing is used as a medicine box. The wing and the ring The medicine cartridge of the present invention in which the hollow structure is integrally formed is compared with the comparative example in which the components are separately produced. The latter needs to support the annular support portions of each wing (a structure similar to the inner circular surface of the hollow structure). The medicine box does not need this. Therefore, the medicine box of the present invention can lengthen the length of the wing, generate stronger airflow and contact with the medicine, and do not weaken the airflow due to the relationship of the wing. Therefore, it is known that The integration of the airfoil wing and the hollow structure can help improve the dispersion efficiency. In addition, from the production point of view, after the wing and the hollow structure are integrated, there is no need to combine the two separately after manufacturing. Especially for individual When manufacturing the wing part, when installing it in a hollow structure, it must be noted that the wing part cannot block the opening of the round surface in the hollow structure body, which makes it troublesome when combining. The hollow structure and When the parts are integrated, at the design stage, the wings are designed at non-opening positions without blocking the circular surface of the hollow structure. The paper size applies to the Chinese National Standard (CNS) A4 (210X297 mm) -9 -534796 Α7 Β7 V. Description of the invention (9 openings, which greatly increases the production volume. Embodiments of the invention The medicament volatilization device in the present invention drives the medicament box containing the medicament impregnated body in a driving manner, and the medicament is gradually caused by the centrifugal force The impregnated body works, and the agent is volatilized at room temperature. The centrifugal force of the impregnated body of the drug is achieved to achieve the following effects, which contribute to the stable volatilization of the drug after long-term use. Stored in the medicine box. However, each of the medicine impregnated bodies is not fixed. When the medicine box is flushed and moved, the medicine impregnated body also moves with it, and the storage state changes accordingly. However, during use, the centrifugal force acts on the drug impregnated body, and it is squeezed to the outer round surface side of the drug box, and it returns to a good retracted state again. 2) With the release of the centrifugal force, each of the drug impregnated bodies also moves to a certain extent with the rotation or movement of the drug cartridge, changing its position. Therefore, as the effect of centrifugal force on the medicine box is cancelled, the medicine impregnated body is also moved, and the stirring effect is achieved. 3) The centrifugal force acts on the medicament impregnated body, so that the medicament inside the medicament impregnated body is squeezed out of the surface due to the centrifugal force, and the air flow is promoted by the rotation of the medicament box to promote evapotranspiration. Therefore, the medicament inside the medicament impregnated body can be effectively evacuated. The above-mentioned centrifugal force is determined by the rotation state of the medicine box. For example, the centrifugal force is 1/1 0 0 0 ~ 100 times the acceleration of gravity (9.8xl02cm / s2), that is, 9.8 × ΙΟ — ^ ιη / This paper size applies the Chinese National Standard (CNS) A4 specification (21 〇X297mm) Ί — J ------- ^^ 衣-(Please read the precautions on the back before filling this page) Order printed by the Intellectual Property Bureau Staff Consumer Cooperatives of the Ministry of Economics-10-534 796 A7 B7 V. Description of the invention (g s2 ~ 9 · 8x 104cm / s2. In the medicine scattering device of the present invention, the medicine box is a ring-shaped hollow structure formed with a hollow portion for storing a medicine impregnated body. In order to obtain a desired amount of evaporation The size of the hollow structure can be changed according to the amount of the impregnated body. The medicine box can be of any shape. For example, the cross-section of the hollow structure can be rectangular. For the production of the hollow structure, it can be retracted inside. For a drug-impregnated body, the above-mentioned hollow structure is ideally constituted by a main body portion having a ring groove and a groove cover. In the present invention, the ring-shaped hollow structure constituting the medicine box has an inner and outer circle. There are openings on the surface, which is a way to disperse the medicine. Air holes. In order to obtain sufficient air permeability, the openings can be arbitrarily designed, but the ratio of the total area of the openings to the total area of the round surface of the medicine cassette is preferably set between 1: 1 and 1: 2. The shape of the openings can be It is composed of a narrow opening or a fine net fixed by a ring. Most parallel openings are suitable. In addition, in order to prevent the medicine from being scattered by the medicine impregnated body in the medicine box before use, the opening of the medicine box is It is preferable to seal the masking member such as an adhesive tape. Since the masking member must be removed during use, a tape or the like that can be easily peeled off is preferred. The medicine cartridge of the present invention does not block the opening of the circular surface inside the annular hollow structure. Position, integrated with the wing extending to the center of the hollow structure. Therefore, the wing has a shape that promotes the airflow of the inner circle of the hollow structure to the outer surface with the rotation of the medicine box. The length of the wing is not There are special restrictions, but 5 mm is appropriate. This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) 7--J ------ clothing-- (Please read the precautions on the back first Fill out this ) Order printed by the Intellectual Property Bureau's Consumer Cooperatives of the Ministry of Economic Affairs -11-534796 A7 B7 V. Description of the invention (^ (Please read the precautions on the back before filling this page) The shape can be changed to adjust the rotary medicine box. The strength of the airflow. For example, the longer the wing, the stronger the airflow. In addition, if the wing is curved or curved, it can send more air to the side of the outer surface of the hollow structure. The ring-shaped center is provided with a rotary support shaft which can be connected with a driving part for rotating the medicine box, and a shaft center part which is connected with the support shaft. The shaft center part tightly connects the medicine box and the rotation support shaft. For example, a cylindrical material is used to tightly connect the rotary support shaft. The shaft center portion is connected to the hollow structure by a plurality of spoke portions. The spokes can be of any number, such as 2 to 4, but it is advisable to use 3 or 4 spokes to connect the shaft and the hollow structure. In the present invention, from the viewpoint of processability and usability, it is preferable to produce the resin from polyester. Polyester resins such as polyethylene terephthalate, polybutylene terephthalate, transparent plastic resin P AR, polycarbonate. Among them, polyethylene terephthalate is preferred. Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs. In the present invention, the viscosity limit of the above polyethylene terephthalate is phenol / 1,1,2,2-tetrachloroethane (weight ratio of two 1/1) of the mixed solvent, it is preferable that the measurement at 25 ° C is 0 · 7 d 1 / g or less. When the viscosity of polyethylene terephthalate is limited to this range, the strength and formability of the medicine box in the present invention will be better, the medicine ingredients will not be lost during use, and the medicine ingredients can be slowly and effectively released. . In addition, as long as the characteristics of the present invention are not impaired, a slip agent (such as stone trowel, aliphatic ester, aliphatic alcohol, etc.), a stabilizer (such as containing calcium, zinc compounds, etc.), and a dashi may be added to the above resin. Strength reinforcing agent, antioxidant, ultraviolet absorber, weather resistance improver, pigment, processing aid or resistance to this paper. Applicable to China National Standard (CNS) A4 specification (210X297 mm) -12- 534796 A7 B7 V. Description of the invention () 0 thermal modifiers. 1—1 — ^ --- #! (Please read the precautions on the back before filling out this page) The shape of the medicament impregnated body used in the medicament dispersion device of the present invention can be variously changed, such as spherical, oval , Egg-shaped, cylindrical, angular column-shaped, rod-shaped, disc-shaped, angular-plate-shaped, irregular and so on. In particular, a granular pharmaceutical impregnated body having an average outer diameter of 3 mm to 10 mm, which is 1 to 3 times the aforementioned opening portion, is preferable. When a drug-impregnated body having such a size and shape is used, the internal drug gradually moves to the surface, which can maintain a long-term and stable volatility. Conversely, if the average outside diameter of the impregnated body of the medicine is less than 3 mm, the medicine will be excessively quickly dispersed, causing the question of whether the bactericidal efficacy is sustainable. The porosity of the above-mentioned pharmaceutical impregnated body in the medicine box (the internal volume ratio of the gap of the unfilled pharmaceutical impregnated body) is 20% to 70%, preferably 25% to 65%, especially 3 0% to 60% is preferred. When the porosity is less than 20%, it is difficult for air to pass through the medicine box, and a sufficient amount of medicine is not ensured. In contrast, when the porosity exceeds 70%. The short contact time between the air and the medicament does not ensure a sufficient volatile amount of the medicament. Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs. The above-mentioned medicament impregnated body can be adjusted to a fluctuating volume of 0. 01 to 0.6 mg per hour, and a medicament with an insecticidal effect of 10. Such a medicine is specifically exemplified by a volatile synthetic pyrethroid insecticide, which is a phenol ester compound containing a fluorine-substituted group as shown in the general formula (I). This paper size applies the Chinese National Standard (CNS) A4 specification (21〇 < 297mm) -13- 534796 A7 B7 V. Description of the invention (heart
(式中，X及Y爲相同或不同之氫原子、甲基、鹵素 原子或二氟甲基；z爲氫原子、氟原子 '甲基、甲氧基或 炔丙基。） 一般式（I )所顯示之化合物之具體實例爲，2 , 3，5，6 —四氟苯甲基—除蟲菊酸、2，3，5，6 — 四氟苯甲基一 2，2 -二甲基一 3 -（1 一丙烯基）環丙 烷羧酸、4 一甲基—2，3，5，6 —四氟苯曱基一除蟲 菊酸、4 一甲基—2，3，5，6 -四氟苯甲基一2，2 一二甲基一 3 -（2，2 -二氯乙烯基）環丙烷羧酸、4 —曱基一2，3，5，6 —四氟苯甲基一2，2 —二甲基 —3 -（2，2 -二氟乙烯基）環丙烷羧酸、4 一甲氧基 甲基—2，3，5，6 —四氟苯甲基一除蟲菊酸、4 —甲 氧基甲基一 2，3，5，6 —四氟苯甲基一2，2 —二甲 基一 3 -（1—丙烯基）環丙烷羧酸、2，3，4，5， 6 —五氟苯甲基一 2，2 —二甲基一 3 —（2 —氯—2 — 三氟甲基乙烯基）環丙烷羧酸、4 一炔丙基-2，3 ’ 5，6-四氟苯甲基一 3— (1 —丙烯基）一 2，2 -二 甲基環丙烷羧酸、4 一甲氧基甲基—2，3，5，6 —四 氟苯甲基一 2，2，3，3 -四甲基環丙烷羧酸以及4 一 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） Ί — ^-------- (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部智慧財產局員工消費合作社印製 -14- 534796 A7 __B7 五、發明説明（七 炔丙基—2 ’ 3，5，6 -四氟苯甲基—2，2，3，3 一四甲基環丙烷羧酸。 (請先閱讀背面之注意事項再填寫本頁) 上述之化合物包括不對稱碳原子及二重結合，亦可存 在光學異構物及幾何異構物。當然也可使用該異構物或異 構物間之任意混合物。 另外，上述之藥劑含浸體亦可含有一種或二種以上之 藥劑。 另一方面，在以往作爲加熱使用之殺蟲劑，其有效成 份如丙儲除蟲菊酯（allethrin)除蟲菊素（pyrethrin)等，因 在常溫下缺乏揮散性，並不適用於本發明之藥劑揮散裝 置。即使是合成除蟲菊精類殺蟲劑，如具有高蒸氣壓之甲 基柳丁安醇（methylventolin)，爲有效地發揮殺蟲效力， 每小時須有2 m g之揮散量，同樣地亦不適宜。 經濟部智慧財產局B工消費合作社印製 上述藥劑含浸體以含有6 Omg以上爲宜。少於6 〇 m g時，有殺蟲效力不彰之虞。藥劑含浸時因需要可使用 溶劑、稀釋劑、界面活性劑、分散劑、徐放化劑等已知之 各種含浸方法。在不影響藥劑之揮散下，可含有安定劑、 香料、著色劑、帶電防止劑等。亦可添加其他殺蟲劑之禁 忌成份，揮散性高之防蟲香料如日扁柏醇（hinokitiol)、香 芹酮（carvone)、黃樟素（safrole)、玫瑰醇（citronellol)、桂 皮醛等或殺蝨劑、殺菌劑、消臭劑等，成爲多目的之藥劑 組成物。 藥劑含浸體之材質可爲紙、紙漿、粘膠等纖維素載體 或是環丙基甲酸乙烯基樹脂、鏈烯烴聚合體等合成樹脂載 本紙張尺度適用中國國家標準（CNS ) A4規格（210X29?公釐） -15- 534796 A7 B7 五、發明説明（）3 體、珪酸鈣等無機載體等。其中以自然界之紙、紙漿、纖 維素載體或是合成樹脂載體、或是其混合物爲基材尤佳。 (請先閱讀背面之注意事項再填寫本頁) 本發明之藥劑揮散裝置中，將大小、形狀、含有藥 劑、材質等相異之多種類之藥劑含浸體，以適宜之比率混 合，收放於藥劑匣中。同時使用揮散特性、效能等不同之 藥劑含浸體，可達到複合性殺蟲、防蟲之目的、 關於本發明之藥劑揮散裝置中，馬達與電源內藏於裝 置本體中，爲回轉藥劑匣之驅動方法。由延長藥劑揮散裝 置使用時間之觀點來看，該馬達以省電型爲宜。例如，一 個2 · 0至3 · 0V電池可持續500至2000 r P m，3 0 0小時以上。另外，電源以3 . 0至6 . 0 V乾電池或將交流電源經由轉接器作電壓轉換成3 . 0至 6 · 0 V之直流電源等亦可。利用交流電源可得到更安定 之藥劑揮散性能及確保經濟效應，但如在戶外使用時，能 與其他電源倂用更佳。 經濟部智慧財產局員工消費合作社印製 本發明之藥劑揮散裝置中，在構造上爲使藥劑匣回 轉，而露出藥劑匣，引起安全上的問題。因此將藥劑匣放 入裝置本體中，並加上蓋子。但是該蓋子以不防礙藥劑之 揮散爲限，蓋子亦設有開口部且手指等亦不會接觸到藥劑 匣爲宜。另外，藥劑用畢更換藥劑時，蓋子安裝於裝置本 體上爲宜。 本發明之藥劑揮散裝置中，改變上述各構成之種種要 素，例如藥劑匣的大小、藥劑匣開口部之總面積、翼部的 大小及形狀、藥劑匣中藥劑含浸體之量及充塡率、藥劑含 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） -16- 534796 A7 _ B7_ __ 五、發明説明（)4 (請先閱讀背面之注意事項再填寫本頁) 浸體中含有之藥劑種類及量、藥劑含浸體之大小及形狀、 藥劑匣之回轉速度等，則可任意變化藥劑含浸體中藥劑揮 散量及藥劑揮散之持續時間。關於藥劑揮散裝置’由實際 使用之觀點而言，藥劑含浸體以每小時揮散量〇 . 〇 1至 0 . 6 m g且持續1 8 0小時以上揮散藥劑爲佳。 本發明之藥劑揮散裝置，並具備有藥劑殘量液晶顯示 器及/或電池殘量液晶顯示器。這些顯示功能由中央處理 機（C P U )或記憶體控制，可辨識有效使用期各異之數 種（通常爲2至3種）藥劑匣。在藥劑匣的對面’放置磁 氣官能掃描器或光掃描器，將感知到的信號傳達予C P U 而辨識藥劑匣的種類，進而顯示藥劑殘量。另外，因應藥 劑匣的種類，可設定有效使用時間，如2 4 0小時（如一 日1 2小時使用爲2 0天）、3 6 0小時（如一日1 2小 時使用爲3 0天）、7 2 0小時（如一日1 2小時使用爲 6 0 天）。 經濟部智慧財產局員工消費合作社印製 另外，控制藥劑殘量顯示功能之方式可有許多種，可 採用如馬達在所定量以上之電壓下運作時，內藏之RC發 信電路發出固有的電波信號，以感應到的電波信號測定馬 達之運作時間，並變換爲藥劑殘量顯示。通常具備有記憶 體，即使關掉電源，計時器的資料並不會消失而保存著。 此外，更換藥劑匣後按重新設定按鍵，即可重新設定測定 馬達運作時間的程式。 可任意設計藥劑殘量液晶顯示器之形狀或顯示方式。 如因應藥劑匣之種類，可設計數個棒狀之液晶顯示部，或 本纸張尺度適用中國國家標準（CNS ) A4規格（210X：297公釐） -17- 534796 A7 B7 五、發明説明（)5 設計可作切換式顯示之單一液晶顯示器。 (請先閲讀背面之注意事項再填寫本頁) 電池殘量顯示功能，由顯示部、電壓低下判別電路以 及辨識電池電壓進而控制顯示功能之c P U所構成。可任 意設計顯示電池殘量液晶顯示器之形狀或顯示方式，與藥 劑殘量液晶顯示器形成一體化或分別設計亦可。 上述之藥劑或電池之殘量顯示方法，可適當地採用如 以棒狀的大小、顯示個數的減少、或爲明白顯示藥劑匣或 電池之更換時期，在使用終點時以閃滅燈顯示亦可。 參考以下各圖，更加詳細說明本發明之裝置。 如圖1至圖4所示，於裝置本體1之凹形部1 1收放 藥劑匣2，並支持其自由地回轉，匣中放置藥劑含浸體 3 ’以電池5驅動馬達4使之回轉。另外，並加上蓋子6 使藥劑匣不會露出。 裝置本體1之凹形部1 1中收放藥劑匣2，內藏以電 池5及馬達4爲運轉方法之部材。在其表面設有控制藥劑 匣2之運轉/停止之電源開關1 2，更設計有不防礙藥劑 揮散之開口部1 3。 經濟部智慧財產局員工消費合作社印製 另外，在裝置本體1的裏面（在設計藥劑匣之另一 面）設計有吊環1 4，可吊掛於衣物上，另在裝置本體1 上有吊下部1 5 ’可穿過繩子掛於脖子上，使藥劑揮营女 裝置易於攜帶。由攜帶面觀點來看，在裝置本體1的大小 儘可能越小越好。 如圖4所示，藥劑含浸體3收放於中空構造體2 1 內。藥劑含浸體3在其內並無緊密充塡之必要。因爲由藥 本紙張尺度適用中國國家標準（CNS ) Α4規格（21〇><297公釐） -18- 534796 A7 B7 五、發明説明（)6 劑匣2所產生之離心力使藥劑含浸體3向藥劑匣2之外圓 面側壓擠，達成外圓面之藥劑含浸體3成緊密充塡狀態。 (請先閱讀背面之注意事項再填寫本頁) 爲防止飛散，藥劑含浸體3之大小必須至少要比外圓 面開口部2 2及內圓面開口部2 3之尺寸大。 馬達4位於藥劑匣2之下，以馬達連接部1 6安裝於 裝置本體1。再與藥劑匣2之回轉支持軸2 4連接於藥劑 匣2之軸心部2 5。爲不引起馬達於運轉時滑動，必須強 化馬達4與回轉支持軸2 4以及回轉支持軸2 4與藥劑匣 2之軸心部2 5之連接。但爲使藥劑含浸體3中藥劑用 盡，更換藥劑匣2時，仍以易於分離藥劑匣2及馬達4爲 宜。 馬達4是由裝置本體1中之電池5所驅動。在電池5 使用壽命用盡時，更換電池之開口部以在裝置本體1中爲 宜。 經濟部智慧財產局員工消費合作社印製 使用本發明之藥劑揮散裝置時，藥劑匣2會高速回 轉。爲避免手指等接觸。收放於裝置本體1之凹形部 1 1，並以蓋子6蓋上。爲避免防礙藥劑之揮散，於蓋子 上設有開口部6 1。開口部6 1的大小以越大越好，但亦 會造成蓋子強度低下，故於開口部6 1之表面設計有補強 部6 2，因此既可確保蓋子6之強度亦可擴大開口部6 1 之大小。 另外，並設計有更換藥劑匣2時可打開蓋子之開關按 鍵6 3。 關於裝置本體1中藥劑匣2及蓋子6之材質，並未有 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） -19- 534796 A7 _— _B7____ 五、發明説明（ (請先閱讀背面之注意事項再填寫本頁) 特別限制。從生產性、成形性、價格、重量等方面考量， 以塑膠樹脂，特別是以聚酯樹脂（如粘度限制爲〇 . 7 d 1 / g以下之聚對苯二甲酸乙二醇酯）製作爲宜。 參考圖5至圖7，再詳細說明藥劑匣2之構造。 藥劑匣2爲斷面爲長方形之環狀中空構造體2 1，收 放於裝置本體1之凹形部1 1，其中空構造體2 1中收放 藥劑含浸體3。中空構造體2 1的大小，因藥劑含浸體3 之收放量及翼部2 6之長度而異。 在藥劑匣2之內外圓面分別設有外圓面開口部2 2及 內圓面開口部2 3。兩開口部均設計有多數之平形細隙， 爲藥劑含浸體3中揮散藥劑之通氣孔。外圓面開口部2 2 及內圓面開口部2 3之大小越大，藥劑揮散速度越快。 以藥劑匣2爲中心，其內圓面向之延伸成許多翼部 2 6。以不阻塞內圓面開口部2 3而與藥劑匣2 —體成 形，成彎曲板狀。隨著藥劑匣2之回轉，翼部可促進由中 空構造體2 1內圓面向外圓面之空氣流動。 經濟部智慧財產局員工消費合作社印製 如此彎曲板狀的翼部2 6可捕捉更多的空氣，因而可 送出更強之氣流。 如本發明中，收放藥劑之中空構造體2 1與翼部2 6 一體成形爲藥劑匣2。其與分開成形後組成之藥劑匣相比 較，具有以下之特徵。 1 ) 一體成形之藥劑匣比分開組成之藥劑匣，可有較 長之翼部，能產生更強之氣流。 2 ) —體成形之藥劑匣，其藥劑含浸體與翼部之翼片 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） -20 - 534796 A7 B7 五、發明説明（士 間之間隔較短。所以在氣流變弱之前，能直接藥劑含浸體 與接觸。 (請先閱讀背面之注意事項再填寫本頁) 3 )無分別製造組裝之必要。 4 )可省略組合時，爲避免阻塞中空構造體之內圓面 開口部，必須正確接合之作業。 上述之1 )及2 )之特徵爲，提升由藥劑匣2中收放 之藥劑含浸體3之藥劑揮散率，在藥劑含浸體、藥劑匣之 回轉率等條件爲一定下時，中空構造體2 1與翼部一體成 形之本發明之藥劑匣2，比分開成形後組成之藥劑匣，可 揮散更多藥劑。換言之，若使用本藥劑匣，用較少的藥劑 含浸體或較少的藥劑匣回轉數，即可達成同樣的藥劑揮散 量，亦可延長藥劑揮散裝置之使用壽命。 上述之3 )及4 )之特徵爲，可高度提升本發明中藥 劑匣2之生產量。 經濟部智慧財產局員工消費合作社印製 藥劑匣2於環狀中空構造體2 1之中心位置具有軸心 部2 5。由圖可知，軸心部2 5是與回轉支持軸2 4緊密 結合之圓柱體。軸心部2 5以輪輻部2 7是與中空構造體 2 1緊密結合。 藥劑匣2是由環狀溝槽之本體部份2 8與溝槽蓋2 9 所構成。可易於製作藥劑匣2，及收放藥劑含浸體3於中 空構造體2 1內部。關於本體部份2 8與溝槽蓋2 9之接 合’例如可在溝槽蓋2 9之表面設計突起以便於嵌合，當 然以結合劑使雙方接合亦可。 其次是，本發明之藥劑揮散裝置中，並備有藥劑及電 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） -21 - 534796 A7 ____B7 _ 五、發明説明（么 (請先閱讀背面之注意事項再填寫本頁) 池之殘量顯示功能。參考圖8至圖1 0，並予說明。圖8 是該裝置之斜視圖，圖9是斷面圖，圖1 〇是電子電路 圖。以下是僅說明與上述不同之部分。 該裝置以乾電池，及以A C轉接器3 4，電線3 5及 連接器3 6轉爲直流電源3 7爲電源來源，爲兩用式。 裝置本體1的上面，電源開關1 2的附近有可目視之 棒狀藥劑殘量液晶顯示器7與電池殘量液晶顯示器8，並 配置有重新設定按鍵9。CPU用電源電路基盤3 0或馬 達用電源電路基盤3 1與之連接並控制。並設計出以磁氣 官能掃描器3 3來感應安裝在藥劑匣2之磁氣帶3 2，以 辨識藥劑匣2之種類。本例是設定可裝塡使用時間爲 3 6 0小時及7 2 0小時之藥劑匣2，藥劑殘量液晶顯示 器7可辨別藥劑匣2之種類並由液晶顯示其殘量。電池殘 量液晶顯示器8由液晶顯示其電池殘量。另外，換入未使 用之藥劑匣2，按重新設定按鍵，即可重新設定計量藥劑 殘量之程式。 經濟部智慧財產局員工消費合作社印製 實施例 由以下之實施例及試驗例，爲本發明做更具體之說 明，但此爲說明本發明之用，本發明並不只限於此。 實施例1 使用以中空構造體與翼部一體成形之藥劑匣 爲藥劑揮散裝置之製作1 製作外徑6 2mm、內徑4 4mm、高度外寸爲1 3 本紙張尺度適用中國國家標準（CNS ) A4規格（21〇Χ297公釐) -22- 534796 A7 B7 五、發明説明（充 (請先閱讀背面之注意事項再填寫本頁) mm、斷面爲長方形之環狀中空構造體。該中空構造體之 中空部之外徑6 Omm、內徑4 2mm、高度爲1 1 mm，體積爲1 5 · 8 c m3。該中空構造體之外圓面設計 有4 0個等間隔，寬度2 m m之細隙狀之開口部。藥劑匣 之內圓面有2 4個長度約5mm之翼部，以一定之角度傾 斜與中空構造體結合形成藥劑匣。使得中空構造體的內壁 至翼部先端之距離爲7 m m。另外，在藥劑匣中心部設有 圓柱體之軸心部，該軸心部以三根輪輻部與中空構造體相 連接。 以此製作成之藥劑匣安裝乾電池2個（合計3 . 0 V )作爲驅動馬達。以此藥劑揮散裝置進行以下之殺蟲試 驗。 實施例2 使用中空構造體與翼部一體成形之藥劑匣爲 藥劑揮散裝置之製作2 經濟部智慧財產局員工消費合作社印製 將交流電源經由A C轉接器轉爲D C 4 . 5之直流電 源，或是單3乾電池2個（合計3 · 0 V )，以上任一電 源都可爲驅動馬達所構成之藥劑揮散裝置。其他構成如實 施例1同樣地製作藥劑匣。 比較例1 使用以中空構造體與翼部分別成形組合之藥劑 匣爲藥劑揮散裝置之製作 與實施例1同尺寸，製作有開口部之環狀中空構造 體。關於翼部則具有與中空構造體的內徑相當大小之外 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） — -23- 534796 A7 B7_ 五、發明説明（ (請先閱讀背面之注意事項再填寫本頁) 徑，備有軸心部及3根輪軸部之熱風風扇’該風扇插入環 狀中空構造體，成爲藥劑匣。其結果爲，中空構造體的內 壁至翼部先端之距離爲7mm，與實施例1相同。但是翼 部之長度約4 . 0 m m，比實施例1藥劑匣之翼部短了 1.0mm。 試驗例 將殺蟲藥劑含浸於各種含浸材料中而得到藥劑含浸 體，收放於實施例1與比較例1之藥劑匣，安裝於本發明 之藥劑揮散裝置，每日使用1 2小時之條件下，於第1 天，第1 5天，第3 0天，分別進行藥劑揮散量測定及殺 蟲效力試驗。 殺蟲效力試驗依照以下之順序進行連續通氣法。 殺蟲效力試驗順序 經濟部智慧財產局員工消費合作社印製 1 ·內徑2 0 cm、高度爲4 3 cm之塑膠圓筒2個 重疊，其上放1個以1 6網目之金屬網分隔上下段，其內 徑及高度均爲20cm之圓筒，在其上再加1個內徑20 cm局度爲2 0 cm之圓筒。 2 ·將這4層圓筒置於台上，台的中央（最下層之圓 筒中）放置藥劑揮散裝置，揮散藥劑含浸體中之藥劑。 3 ·之後，上方之第2個圓筒內放入約2 0隻試驗用 蚊，觀察隨時間經過蚊子之仰翻數。 另外，設定以溫度1 6 0 t：之發熱體放熱板，蒸散含 本紙張尺度適用中國國家標準（CNS ) A4規格（210X 297公釐） -24- 534796 A7 B7__ 五、發明説明（么 有右旋，順位，反位-丙烯除蟲菊酯之蚊香片之初期仰翻 效果爲1 . 0 0，殺蟲效力以相對有效比顯示。 (請先閱讀背面之注意事項再填寫本頁) 改變殺蟲劑種類及量、含浸體材料及其顆粒直徑、藥 劑匣之空隙率、馬達之回轉數，重複上述之試驗。 試驗結果如表1及表2所示。 表中之粘珠爲L E G〇株式會社製之粒狀發泡纖維珠 子的商品名。 使用如下所示之化合物A至K爲藥劑。 化合物A: 2，3，5，6 -四氟苯甲基一除蟲菊酸 化合物B : 2，3，5，6 -四氟苯甲基—2，2 — 二甲基一 3 -（ 1 一丙烯基）環丙烷羧酸 化合物C : 4 一甲基—2，3，5，6 —四氟苯甲基 -除蟲菊酸 化合物D : 4 —甲基一 2，3，5，6 —四氟苯甲基 —2，2 - 一甲基—3 -（2，2 -二氯乙烯基）環丙院 羧酸 化合物E : 4 —甲基—2，3，5，6 —四氟苯甲基 經濟部智慧財產局員工消費合作社印製 —2 ’ 2 —一甲基—3 -（2，2 —二氟乙儲基）環丙院 羧酸 化合物F : 4 —甲氧基甲基—2，3，5，6 —四氟 苯甲基-除蟲菊酸 化合物G : 4 —甲氧基甲基—2，3，5，6 —四氟 苯甲基一 2，2-二甲基—3 -（1 一丙烯基）環丙院竣 酸 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐) ^ ~ -25- 534796 A7 _____B7 五、發明説明（4 化合物 Η • 2 3 4 ? 5 6 — 五 氟 苯甲基 — 2 9 2 — -二甲 基 — 3 — ( 2 — 氯 — 2 — 二 氟 甲 基 乙烯基 ) 丙 烷羧酸 化合 物 I ： 4 一 炔丙 基 — 2 3 5 6 - -四 氟 苯 甲 請 先 閲 基- -3 - ( 1 — 丙 烯 基 ) — 2 5 2 — 一 甲 基 環丙烷 羧 酸 讀 背 1¾ 化合 物 J ； 4 一 甲 氧 基 甲 基 — 2 5 3 5 5 ， ，6 — 四 氟 意 苯甲基一 2 5 2 5 3 3 — 四 甲 基 丙 院 羧 酸 事 項 再 化合 物 Κ * 4 — 炔丙 基 — 2 3 5 ? 6 - -四 氟 苯 甲 寫 本 基- -2， 2 ? 3 3 — 四 甲 基 環 丙 院 羧 酸 頁 表1 使用實施例1之藥劑匣爲藥劑揮散裝置之試驗結果 藥劑(mg) 含浸體材料粒徑 空隙率(％) 馬達回轉數 揮散量(⑽ ；/12h) ----' 殺蟲效力 (mm) (rpm) Id 15d 30d Id 15d 30d 1 化合物A 粘珠3 40 1800 7.1 7.1 6.9 3.9 ------ 3.8 3.8 2 化合物B 紙漿4 20 2000 5.8 5.7 5.7 2.8 2.7 2.7 3 化合物C 乙烯-醋酸乙烯7 50 1300 2.7 2.6 2.5 2.3 2.2 2? 4 化合物D 紙6 65 1100 3.9 3.8 3.7 3.2 3.2 3.1 5 化合物E 聚丙烯5 25 1400 3.7 3.7 3.6 2.9 2.8 2.8 6 化合物F 紙漿8 70 200 1.2 1.0 1.0 2.6 2.5 2.5 7 化合物G 粘珠3 35 1200 2.1 2.0 2.0 3.4 3.4 34 8 化合物Η 紙5 40 500 1,3 1.3 1.2 2.4 2.3 — 9 化合物I 粘珠4 30 1100 3.3 3.2 3.2 3.0 1 --- 2.9 J 2.9 10 化合物J 粘珠3 30 1200 4.5 4.4 4.4 2.9 2.8 28 11 化合物Κ 粘珠4 30 1300 4.4 4.3 4.2 2.8 ----- 2.7 .2.7 經 濟 部 智 慧 財 產 局 員(In the formula, X and Y are the same or different hydrogen atom, methyl group, halogen atom or difluoromethyl group; z is a hydrogen atom, fluorine atom 'methyl group, methoxy group or propargyl group.) General formula (I ) Specific examples of the compounds shown are 2, 3, 5, 6-tetrafluorobenzyl-pyrethrin, 2,3,5,6-tetrafluorobenzyl-2,2-dimethyl 1- (1-propenyl) cyclopropanecarboxylic acid, 4-methyl-2,3,5,6-tetrafluorophenylfluorenyl-pyrethrin, 4-methyl-2,3,5,6 -Tetrafluorobenzyl-2,2-dimethyl-2,3- (2,2-dichlorovinyl) cyclopropanecarboxylic acid, 4-fluorenyl-2,3,5,6-tetrafluorobenzyl One 2,2-Dimethyl-3-(2,2-difluorovinyl) cyclopropanecarboxylic acid, 4-monomethoxymethyl-2,3,5,6-tetrafluorobenzyl mono-pesticide Chrysanthemic acid, 4-methoxymethyl-2,3,5,6-tetrafluorobenzyl-2,2-dimethyl-1 3- (1-propenyl) cyclopropanecarboxylic acid, 2,3, 4,5,6-Pentafluorobenzyl-2,2-dimethyl-1 3- (2-chloro-2-trifluoromethylvinyl) cyclopropanecarboxylic acid, 4-propynyl -2,3 '5,6-tetrafluorobenzyl-3- (1-propenyl) -2,2-dimethylcyclopropanecarboxylic acid, 4-monomethoxymethyl-2,3,5 , 6 —Tetrafluorobenzyl-1, 2,2,3,3 -tetramethylcyclopropanecarboxylic acid and 4 — Paper size applicable to China National Standard (CNS) A4 (210X297 mm) Ί — ^ --- ----- (Please read the notes on the back before filling this page) Order printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs -14- 534796 A7 __B7 V. Description of the invention (Heptapropynyl-2 '3,5 , 6-tetrafluorobenzyl-2,2,3,3-tetramethylcyclopropanecarboxylic acid (Please read the notes on the back before filling this page) The above compounds include asymmetric carbon atoms and double bonds There may also be optical isomers and geometric isomers. Of course, the isomers or any mixture between the isomers may also be used. In addition, the above-mentioned pharmaceutical impregnated body may also contain one or two or more pharmaceutical agents. On the one hand, in the past, as an insecticide used for heating, its effective ingredients such as allethrin and pyrethrin were Lack of volatility at room temperature, it is not suitable for the medicament volatilization device of the present invention. Even synthetic pyrethroid insecticides, such as methylventolin with high vapor pressure, are effective in exerting insecticidal efficacy. It is necessary to have a volatility of 2 mg per hour, which is also unsuitable. It is advisable that the above-mentioned pharmaceutical impregnated body printed by the Industrial Property Cooperative Cooperative of the Intellectual Property Bureau of the Ministry of Economy should contain more than 6 Omg. When it is less than 60 mg, there is insecticide Risk of ineffectiveness. When impregnating a drug, various known impregnation methods such as a solvent, a diluent, a surfactant, a dispersant, and a radiochemical agent can be used as required. It can contain stabilizers, perfumes, colorants, antistatic agents, etc. without affecting the volatility of the medicine. Can also add other contraindicated ingredients of insecticides, highly volatile insect repellents such as hinokitiol, carvone, safrole, citronellol, cinnamaldehyde, etc. or lice Agents, bactericides, deodorants, etc., become multipurpose pharmaceutical compositions. The material of the drug impregnating body can be cellulose carrier such as paper, pulp, viscose or synthetic resin such as cyclopropyl formate vinyl resin, olefin polymer, etc. The paper size is applicable to Chinese National Standard (CNS) A4 specification (210X29? (Mm) -15- 534796 A7 B7 5. Description of the invention () 3 body, inorganic carriers such as calcium osmate, etc. Among them, natural paper, pulp, cellulose carrier, synthetic resin carrier, or a mixture thereof is preferred as a base material. (Please read the precautions on the back before filling this page.) In the pharmaceutical dispersion device of the present invention, various types of pharmaceutical impregnated bodies with different sizes, shapes, containing pharmaceuticals, materials, etc. are mixed at an appropriate ratio and stored in In the medicine box. Simultaneous use of different medicament impregnations such as volatilization characteristics and performance can achieve the purpose of compound insecticide and insect control. Regarding the medicament volatilization device of the present invention, the motor and the power source are built into the device body and are used to drive the rotary pharmacy cartridge method. From the viewpoint of extending the use time of the medicine dispensing device, the motor is preferably a power-saving type. For example, a 2 · 0 to 3 · 0V battery can last 500 to 2000 r P m for more than 300 hours. In addition, the power can be from 3.0 to 6.0 V dry batteries or the AC power can be converted to 3.0 to 6.0 V DC power through the adapter. The use of AC power can obtain more stable pharmacy dispersion performance and ensure economic effects, but it can be used with other power sources better when used outdoors. Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs. In the medicament dispersing device of the present invention, the pharmacy cartridge is exposed in order to rotate the pharmacy cartridge in structure, causing safety problems. Therefore, put the medicine cartridge into the device body and attach the lid. However, the lid is limited so as not to hinder the scattering of the medicine, and the lid is also provided with an opening and the fingers and the like will not contact the medicine box. In addition, when changing the medicine after the medicine is used, it is preferable to attach the cover to the device body. In the medicament volatilization device of the present invention, various elements such as the size of the medicament box, the total area of the opening of the medicament box, the size and shape of the wings, the amount of the medicament impregnated body and the filling rate in the medicament box, The size of the medicine containing this paper applies the Chinese National Standard (CNS) A4 specification (210X297 mm) -16- 534796 A7 _ B7_ __ V. Description of the invention () 4 (Please read the precautions on the back before filling this page) In the immersion The type and amount of the medicine contained, the size and shape of the medicine impregnated body, the rotation speed of the medicine box, etc., the amount of medicine volatilization and the duration of the medicine volatilization in the medicine impregnated body can be arbitrarily changed. From the viewpoint of practical use of the drug dispersing device, it is preferable that the drug impregnated body disperses the drug at an amount of 0.001 to 0.6 mg per hour for more than 180 hours. The medicament volatilizing device of the present invention is provided with a liquid crystal display of a remaining amount of a drug and / or a liquid crystal display of a remaining amount of a battery. These display functions are controlled by a central processing unit (CPU) or memory and can identify several (usually 2 to 3) cartridges with different useful lives. A magnetic-functional scanner or an optical scanner is placed on the opposite side of the medicine cassette, and the sensed signal is transmitted to the CPU to identify the type of the medicine cassette, and the remaining amount of the medicine is displayed. In addition, according to the type of medicine box, the effective use time can be set, such as 240 hours (such as 12 hours a day for 20 days), 360 hours (such as 12 hours a day for 30 days), 7 20 hours (for example, if 12 hours a day is used for 60 days). Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs In addition, there are many ways to control the function of displaying the remaining amount of pharmaceuticals. For example, when the motor is operated at a voltage greater than the specified amount, the built-in RC transmission circuit emits inherent radio waves. The signal is used to measure the operating time of the motor by the sensed radio wave signal, and it is converted into the remaining amount of the medicine. The memory is usually provided. Even if the power is turned off, the timer data will not disappear and will be saved. In addition, the program for measuring the operating time of the motor can be reset by pressing the reset button after replacing the medicine cassette. The shape or display mode of the liquid crystal display of the remaining medicine amount can be arbitrarily designed. According to the type of medicine box, several rod-shaped liquid crystal display parts can be designed, or the size of this paper is applicable to China National Standard (CNS) A4 (210X: 297 mm) -17- 534796 A7 B7 V. Description of the invention ( ) 5 Designed as a single liquid crystal display for switching display. (Please read the precautions on the back before filling this page.) The remaining battery capacity display function consists of a display unit, a low-voltage discrimination circuit, and c P U that recognizes the battery voltage and controls the display function. The shape or display method of the battery residual liquid crystal display can be designed arbitrarily, and it can be integrated with the pharmaceutical residual liquid crystal display or designed separately. The above-mentioned method for displaying the remaining amount of a medicine or a battery can be appropriately adopted, such as a rod-like size, a reduction in the number of displays, or a clear indication of the replacement period of the medicine box or the battery. can. The device of the present invention will be described in more detail with reference to the following drawings. As shown in FIGS. 1 to 4, the medicine box 2 is housed in the concave portion 11 of the device body 1 and supported to rotate freely. A medicine impregnated body 3 ′ is placed in the box to drive the motor 4 to rotate with the battery 5. In addition, the lid 6 is added so that the medicine cassette is not exposed. The medicine box 2 is housed in the concave portion 11 of the apparatus main body 1, and contains a battery 5 and a motor 4 as operating methods. A power switch 12 for controlling the operation / stop of the medicine box 2 is provided on the surface, and an opening 13 is also designed to prevent the medicine from being scattered. Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs. In addition, a ring 14 is designed inside the device body 1 (on the other side of the medicine box), which can be hung on clothing, and a lower part 1 is installed on the device body 1. 5 'can be hung on the neck through a rope, making it easy to carry the device. From the viewpoint of the carrying surface, the size of the device body 1 should be as small as possible. As shown in FIG. 4, the drug impregnated body 3 is housed in the hollow structure 2 1. The drug impregnated body 3 does not need to be tightly packed therein. Because the paper size of the medicine applies the Chinese National Standard (CNS) A4 specification (21〇 < 297 mm) -18- 534796 A7 B7 V. Description of the invention (6) The centrifugal force generated by the reagent box 2 makes the drug impregnated body 3 Squeeze the outer round surface side of the medicine box 2 to achieve a tightly packed state of the medicine impregnated body 3 on the outer round surface. (Please read the precautions on the back before filling out this page.) To prevent scattering, the size of the pharmaceutical impregnated body 3 must be at least larger than the dimensions of the outer surface opening 2 2 and the inner surface opening 2 3. The motor 4 is located below the medicine cassette 2 and is mounted on the apparatus body 1 with a motor connection portion 16. It is connected to the pivot support shaft 24 of the medicine cassette 2 to the shaft center portion 25 of the medicine cassette 2. In order not to cause the motor to slip during operation, it is necessary to strengthen the connection between the motor 4 and the rotation support shaft 24, and the rotation support shaft 24 and the shaft center portion 25 of the medicine box 2. However, in order to use up the medicine in the medicine impregnated body 3, it is preferable to easily separate the medicine cassette 2 and the motor 4 when replacing the medicine cassette 2. The motor 4 is driven by a battery 5 in the apparatus body 1. When the battery 5 has reached the end of its useful life, it is advisable to replace the opening of the battery in the device body 1. Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs When the medicament dispersing device of the present invention is used, the medicament cassette 2 will rotate at a high speed. To avoid contact with fingers. It is put in the concave portion 11 of the device body 1 and closed with a cover 6. In order to prevent the medicine from being scattered, an opening 61 is provided in the lid. The larger the size of the opening 6 1 is, the better, but it also causes the strength of the cover to be low. Therefore, a reinforcing portion 6 2 is designed on the surface of the opening 6 1. Therefore, the strength of the cover 6 can be ensured and the opening 6 1 can be enlarged. size. In addition, it is designed with a switch button 6 3 that can open the lid when changing the medicine box 2. Regarding the material of the medicine box 2 and the cover 6 in the device body 1, there is no paper size applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) -19- 534796 A7 _ — _B7____ 5. Description of the invention ((please first Read the precautions on the back and fill in this page) Special restrictions. From the aspects of productivity, formability, price, weight, etc., plastic resins, especially polyester resins (if the viscosity is limited to 0.7 d 1 / g or less Polyethylene terephthalate) is preferred. The structure of the medicine box 2 will be described in detail with reference to FIGS. 5 to 7. The medicine box 2 is a ring-shaped hollow structure 21 with a rectangular cross section, and is retracted. The medicine impregnated body 3 is housed in the concave portion 11 of the device body 1, and the hollow structure body 21 is 1. The size of the hollow structure body 2 1 varies depending on the amount of the medicine impregnated body 3 and the length of the wings 26. The inner and outer round surfaces of the medicine box 2 are respectively provided with outer round surface openings 22 and inner round surface openings 23. Both openings are designed with a large number of flat narrow gaps for the passage of the medicine in the medicine impregnated body 3. Air holes. The size of the openings 2 2 on the outer surface and the openings 2 3 on the inner surface. The larger, the faster the medicine spreading speed. With the medicine box 2 as the center, the inner circle of the medicine box 2 is extended to form a plurality of wings 26. The medicine box 2 is formed integrally with the medicine box 2 without blocking the inner surface opening portion 23 to form a curved plate. With the rotation of the medicine box 2, the wings can promote the flow of air from the inner circle of the hollow structure 21 to the outer surface. The consumer cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs has printed such curved plate-like wings 2 6 may It captures more air, so it can send out a stronger airflow. As in the present invention, the medicine hollow structure 21 and the wings 2 6 are integrally formed into a medicine box 2. It is similar to the medicine box formed after being formed separately. In comparison, it has the following characteristics: 1) The integrally formed medicine box can have longer wings and can generate stronger airflow than the separately formed medicine box. 2） —A body-formed medicine box, the medicine impregnated body and the wings of the wings. The paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) -20-534796 A7 B7 V. Description of the invention (Shijianzhizhi The interval is short. So the impregnated body can be directly contacted before the air flow becomes weak. (Please read the precautions on the back before filling this page) 3) There is no need to manufacture and assemble separately. 4) When the combination can be omitted, in order to avoid blocking the opening of the inner surface of the hollow structure, the joint must be properly joined. The above 1) and 2) are characterized in that the medicament volatilization rate of the medicament impregnated body 3 stored in the medicament cartridge 2 is increased, and the hollow structure 2 is provided when the conditions such as the medicament impregnated body and the rotation rate of the medicament cartridge are constant. 1 The medicine box 2 of the present invention, which is formed integrally with the wings, can disperse more medicine than the medicine box formed after being separately formed. In other words, if this medicine cassette is used, with less medicament impregnated body or fewer revolutions of the medicine cassette, the same medicine volatilization amount can be achieved, and the service life of the medicine volatilization device can be extended. The above 3) and 4) are characterized in that the production amount of the Chinese medicine cartridge 2 of the present invention can be highly enhanced. Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs, the medicine box 2 has an axis portion 25 at the center of the annular hollow structure 21. It can be seen from the figure that the shaft center portion 25 is a cylindrical body which is closely combined with the rotation support shaft 24. The shaft portion 25 and the spoke portion 27 are tightly coupled to the hollow structure 2 1. The medicine cassette 2 is composed of a main body portion 28 of a circular groove and a groove cover 2 9. The medicine cassette 2 can be easily manufactured, and the medicine impregnated body 3 can be stored in the hollow structure body 21. Regarding the connection of the main body portion 28 and the groove cover 29, for example, a protrusion may be designed on the surface of the groove cover 29 to facilitate fitting, and of course, it is also possible to join both sides with a bonding agent. Secondly, in the medicament volatilization device of the present invention, there are medicaments and electronic paper sizes applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) -21-534796 A7 ____B7 _ V. Description of the invention (why (please first Read the precautions on the back and fill in this page again) The remaining capacity display function of the cell. Refer to Figure 8 to Figure 10 and explain. Figure 8 is a perspective view of the device, Figure 9 is a sectional view, and Figure 10 is an electronic circuit diagram The following is only a description of the differences from the above. This device uses a dry battery, and uses AC adapter 3 4, wire 3 5 and connector 36 to convert to DC power source 37, which is a dual-purpose power source. Device body On the top of 1, there is a rod-shaped liquid medicine remaining amount liquid crystal display 7 and a battery remaining amount liquid crystal display 8 near the power switch 12 and a reset button 9. The CPU power circuit board 30 or the motor power circuit The base plate 31 is connected and controlled. A magnetic functional scanner 3 3 is designed to inductively mount the magnetic tape 3 2 on the medicine box 2 to identify the type of the medicine box 2. In this example, it can be installed and used. Time is 3 60 hours and 7 2 0 hours The liquid medicine display 2 of the medicine remaining amount, the medicine remaining amount liquid crystal display 7 can discriminate the type of the medicine case 2 and display its remaining amount by the liquid crystal. The battery remaining amount liquid crystal display 8 shows the remaining amount of the battery by the liquid crystal. In addition, replace the unused medicine box 2 Press the reset button to reset the formula for measuring the remaining amount of pharmaceuticals. Printed by the Consumers' Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs The following examples and test examples are used to describe the present invention in more detail, but this is The purpose of the present invention is to explain the present invention, and the present invention is not limited to this. Example 1 Production using a medicine box formed of a hollow structure and a wing integrally as a medicine dispersing device 1 Production of an outer diameter of 6 2mm, an inner diameter of 4 4mm, and an outer height It is 1 3 This paper size applies Chinese National Standard (CNS) A4 specification (21〇297297 mm) -22- 534796 A7 B7 V. Description of the invention (fill (please read the precautions on the back before filling this page) mm, broken The surface is a rectangular ring-shaped hollow structure. The hollow portion of the hollow structure has an outer diameter of 60 mm, an inner diameter of 42 mm, a height of 11 mm, and a volume of 1 5 · 8 c m3. Noodle design 40 equally spaced openings with a width of 2 mm. The inner circular surface of the medicine box has 24 wings with a length of about 5 mm. They are combined with a hollow structure at a certain angle to form a medicine box. The distance from the inner wall of the structure to the apex of the wing is 7 mm. In addition, a central axis portion of a cylinder is provided at the central portion of the medicine box, and the central portion is connected to the hollow structure by three spoke portions. Two dry batteries (total 3.0 V) were installed in the medicine box as the driving motor. The following insecticidal test was performed with the medicine dispersing device. Example 2 Production of a medicament dispersing device using an integrally formed medicament box with a hollow structure and wings 2 Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs and converting AC power to DC 4.5 DC power through an AC adapter, Or two single 3 dry batteries (total 3 · 0 V), any of the above power sources can be a medicine dispersing device composed of a driving motor. Other constitutions are the same as those in the first embodiment. Comparative Example 1 Production of a medicine cartridge using a medicine cartridge formed by forming and combining a hollow structure and a wing separately. The same size as in Example 1 was used to produce a ring-shaped hollow structure with an opening. For the wing part, it has a size that is equivalent to the inside diameter of the hollow structure. The paper size applies the Chinese National Standard (CNS) A4 (210X297 mm) — -23- 534796 A7 B7_ V. Description of the invention ((Please read the back first Note: Please fill in this page again.) There is a hot air fan with a shaft center and three wheel shafts. The fan is inserted into a ring-shaped hollow structure and becomes a medicine box. As a result, the inner wall of the hollow structure to the wings The distance at the tip is 7mm, which is the same as in Example 1. However, the length of the wings is about 4.0 mm, which is 1.0mm shorter than the wings of the medicine box of Example 1. The test example is impregnated with various impregnating materials. Obtain the medicament impregnated body, put it in the medicament box of Example 1 and Comparative Example 1, install it in the medicament volatilization device of the present invention, and use it for 12 hours a day on the first day, the 15th day, and the third On day 0, the measurement of the volatility of the agent and the insecticidal efficacy test were performed separately. The insecticidal efficacy test was performed by the continuous ventilation method in the following order. The insecticidal efficacy test sequence was printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs 1 · Inner diameter 20 cm ,high 2 plastic cylinders with a degree of 4 3 cm are overlapped, and a metal mesh with 16 meshes is used to separate the upper and lower sections, and the inner diameter and height of the cylinder are both 20 cm, and an inner diameter is added on top of it A 20 cm cylinder with a length of 20 cm. 2 · Place these 4 layers of cylinders on a table, and place a medicament dispersing device in the center of the table (in the lowermost cylinder) to disperse the medicament in the impregnated body. 3 · After that, put about 20 test mosquitoes in the second cylinder above, and observe the number of mosquitoes turning over time. In addition, set the heat-generating plate of the heating body at a temperature of 160 t: evaporate the paper containing the paper The scale is applicable to the Chinese National Standard (CNS) A4 specification (210X 297 mm) -24- 534796 A7 B7__ V. Description of the invention The insecticidal effect is 1. 0 0, and the insecticidal efficacy is displayed in a relatively effective ratio. (Please read the precautions on the back before filling this page) Change the type and amount of the pesticide, the diameter of the impregnated material and its particles, the porosity of the medicine box, The number of rotations of the motor is repeated. The test results are shown in Tables 1 and 2. In the table The sticky beads are the trade names of granular foamed fiber beads manufactured by LEGO Co. The compounds A to K shown below are used as a medicine. Compound A: 2, 3, 5, 6-tetrafluorobenzyl mono-pesticide Inulin compound B: 2,3,5,6-tetrafluorobenzyl-2,2-dimethyl-1,3- (1-propenyl) cyclopropanecarboxylic acid compound C: 4 monomethyl-2,3 , 5,6-tetrafluorobenzyl-pyrethrin compound D: 4-methyl-2,3,5,6-tetrafluorobenzyl-2,2 -monomethyl-3-(2, 2-Dichlorovinyl) Cyclopropane carboxylic acid compound E: 4-methyl-2,3,5,6-tetrafluorobenzyl Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs—2 '2—A 3- (2,2-difluoroethoxy) cyclopropanecarboxylic acid compound F: 4-methoxymethyl-2,3,5,6-tetrafluorobenzyl-pyrethionate G: 4-methoxymethyl-2,3,5,6-tetrafluorobenzyl-2,2-dimethyl-3-(1-propenyl) cyclopropane acetic acid This paper is suitable for China National Standard (CNS) A4 specification (210X297 mm) ^ ~ -25- 534796 A7 _____B 7 V. Description of the invention (4 compound Η • 2 3 4? 5 6 — pentafluorobenzyl — 2 9 2 — —dimethyl — 3 — (2 — chloro — 2 — difluoromethylvinyl) propanecarboxylate Acid compound I: 4-propargyl— 2 3 5 6--tetrafluorobenzyl Please read the base--3-(1 —propenyl) — 2 5 2 — monomethylcyclopropanecarboxylic acid Read Back 1¾ Compound J; 4 monomethoxymethyl — 2 5 3 5 5,, 6 — tetrafluoros-benzyl — 2 5 2 5 3 3 — tetramethylpropanecarboxylic acid re-compound K * 4 — propargyl — 2 3 5? 6--Tetrafluorobenzyl writing base--2, 2? 3 3 — Tetramethylcyclopropane carboxylic acid page Table 1 Using the medicine box of Example 1 as the test result of the medicine dispersing device mg) Impurity material particle size void ratio (%) Motor rotation number Volatility (⑽; / 12h) ---- 'Insecticide efficacy (mm) (rpm) Id 15d 30d Id 15d 30d 1 Compound A Sticky beads 3 40 1800 7.1 7.1 6.9 3.9 ------ 3.8 3.8 2 Compound B Pulp 4 20 2000 5.8 5.7 5.7 2.8 2.7 2.7 3 Compound C Ethylene-vinyl acetate 7 50 1300 2.7 2.6 2.5 2.3 2.2 2? 4 Compound D Paper 6 65 1100 3.9 3.8 3.7 3.2 3.2 3.1 5 Compound E Polypropylene 5 25 1400 3.7 3.7 3.6 2.9 2.8 2.8 6 Compound F Pulp 8 70 200 1.2 1.0 1.0 2.6 2.5 2.5 7 Compound G Sticky beads 3 35 1200 2.1 2.0 2.0 3.4 3.4 34 8 Compound Η Paper 5 40 500 1,3 1.3 1.2 2.4 2.3- 9 Compound I Sticky Bead 4 30 1100 3.3 3.2 3.2 3.0 1 --- 2.9 J 2.9 10 Compound J Sticky Bead 3 30 1200 4.5 4.4 4.4 2.9 2.8 28 11 Compound K Sticky Bead 4 30 1300 4.4 4.3 4.2 2.8 ----- 2.7.2.7 Member of Intellectual Property Bureau, Ministry of Economic Affairs
X 消 費 合 社 印 製 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） -26- 534796 A7 B7 五、發明説明（么 表2 使用] 比較例1之藥劑匣爲藥劑捐 言散裝置之試驗結果 藥劑(mg) 含浸體材料粒徑 (mm) 空隙率(％) 馬達回轉數 (rpm) 揮散量(mg/12h) 殺蟲效力 Id 15d 30d Id 15d 30d 1 化合物A 粘珠3 40 1800 6.3 6.2 6.2 3.4 3.3 3.3 2 化合物B 紙漿4 20 2000 5.3 5.1 5.1 2.2 2.1 2.0 3 化合物C 乙儲-醋酸乙烯7 50 1300 2.1 1.9 1.9 1.8 1.7 1.6 4 化合物D 紙6 65 1100 3.3 3.2 3.1 2.8 2.7 2.6 5 化合物E 聚丙烯5 25 1400 3.2 3.1 3.1 2.4 2.3 2.3 6 化合物F 紙漿8 70 200 0.6 0.5 0.3 1.9 1.7 1.5 7 化合物G 粘珠3 35 1200 1.5 1.4 1.3 2.9 2.8 2.8 8 化合物Η 紙5 40 500 0.7 0.6 0.6 1.9 1.7 1.7 9 化合物I 粘珠4 30 1100 2.9 2.7 2.6 2.6 2.5 2.4 10 化合物J 粘珠3 30 1200 4.0 3.8 3.7 2.5 2.4 2.4 11 化合物Κ 粘珠4 30 1300 4.0 3.8 3.7 2.3 2.2 2.1 (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製 如表1所示，關於本發明之藥劑揮散裝置，認爲經過 3 0天的長期間，藥劑的揮散量穩定，且保持高度的殺蟲 效力。亦即是，使用具備有實施例1之藥劑匣，揮散量幾 乎不隨時間改變，經過3 0天，其殺蟲效果也幾乎維持一 定，認爲有優異的經時安定性。 相對於此，如表2所示，比較例1中收放藥劑含浸體 之中空構造體與翼部各別成形後組合之藥劑匣，與使用實 施例1之藥劑匣爲藥劑揮散裝置相比較，在揮散效果上， 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） -27- 534796 A7 B7 五、發明説明（4 前者明顯地差了許多。 (請先閲讀背面之注意事項再填寫本頁) 發明之效果 關於本發明之藥劑揮散裝置，因爲以不加熱而利用氣 流促進藥劑含浸體之藥劑揮散之方式，所以使用時無燙傷 之虞，並且能長時間穩定地揮散一定量之藥劑，以往所沒 有之經過長時間仍能維持優異之殺蟲效果。而且具優越的 安全性、使用性等，在蚊子、蒼蠅等衛生害蟲，蚋、蛀 蟲、小蛀蟲、鰹魚蟲等不快害蟲，特別是蚊子之防除用途 上極爲有用的。 另外，關於本發明之藥劑揮散裝置中，以電池運作， 小型且輕量，可適用室內或戶外。如旅行時之室內或露營 之帳棚內，對防止除去衛生害蟲或不快害蟲是非常有幫 助。 經濟部智慧財產局員工消費合作社印製 關於本發明之藥劑揮散裝置中，所使用之藥劑匣，因 收放藥劑含浸體之中空構造體與翼部一體成形，可產生更 強的氣流並且在氣流不減弱之情況下接觸藥劑含浸體，而 提升揮散效率。且無分別製造組裝翼部與中空構造體之必 要，亦可省略組合時，必須正確接合之煩人作業，由生產 觀點而言，是非常有利的。 本發明中之藥劑匣以塑膠樹脂，特別是以聚酯樹脂 (如粘度限制爲0 · 7 d 1 / g以下之聚對苯二甲酸乙二 醇酯）製作，長時間使用時，可無損失地有效地放出藥劑 成份，且在長期間保存時藥劑幾乎沒有損失，是極爲有用 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） -28- 534796 A7 B7 五、發明説明（2^ 的。 (請先閱讀背面之注意事項再填寫本頁) 並具備有藥劑殘量顯示功能或電池殘量顯示功能’可 正確且明瞭地把握藥劑匣或電池的使用期限或殘量，是具 有實用性的。 圖面之簡單說明 圖1是，本發明之藥劑揮散裝置之斜視圖。 圖2是，本發明之藥劑揮散裝置之正面圖。 圖3是，本發明之藥劑揮散裝置之側面圖。 圖4是，圖示圖2之A-A’線之斷面之模式圖。 圖5是，關於本發明之藥劑揮散裝置中之藥劑匣上方 之斜視圖。 圖6是，關於本發明之藥劑揮散裝置中之藥劑匣下方 之斜視圖。 圖7是，關於本發明之藥劑揮散裝置中之藥劑匣，其 分解狀態之斜視圖。 經濟部智慧財產局員工消費合作社印製 圖8是’關於本發明之藥劑揮散裝置所具備之藥劑殘 量顯示功能或電池殘量顯示功能之斜視圖。 圖9是，圖8所示藥劑揮散裝置之斷面圖。 圖1 0是，圖9所示藥劑揮散裝置之電子電路圖。 元件對照表 1 裝置本體 2 藥劑匣 本纸張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） ^ — -29- 534796 A7 B7X The size of the paper printed by the Consumer Cooperative applies the Chinese National Standard (CNS) A4 specification (210X297 mm) -26- 534796 A7 B7 5. Description of the invention (use in Table 2) The medicine box of Comparative Example 1 is for donation Test results of the device Agent (mg) Particle size of impregnated material (mm) Porosity (%) Motor revolution (rpm) Volatility (mg / 12h) Insecticide efficacy Id 15d 30d Id 15d 30d 1 Compound A Sticky beads 3 40 1800 6.3 6.2 6.2 3.4 3.3 3.3 2 Compound B Pulp 4 20 2000 5.3 5.1 5.1 2.2 2.1 2.0 3 Compound C Acetate-Vinyl Acetate 7 50 1300 2.1 1.9 1.9 1.8 1.7 1.6 4 Compound D Paper 6 65 1100 3.3 3.2 3.1 2.8 2.7 2.6 5 Compound E Polypropylene 5 25 1400 3.2 3.1 3.1 2.4 2.3 2.3 6 Compound F Pulp 8 70 200 0.6 0.5 0.3 1.9 1.7 1.5 7 Compound G Sticky beads 3 35 1200 1.5 1.4 1.3 2.9 2.8 2.8 8 Compound Η Paper 5 40 500 0.7 0.6 0.6 1.9 1.7 1.7 9 Compound I Sticky Beads 4 30 1100 2.9 2.7 2.6 2.6 2.5 2.4 2.4 10 Compound J Sticky Beads 3 30 1200 4.0 3.8 3.7 2.5 2.4 2.4 11 Compound K Sticky Beads 4 30 1300 4.0 3.8 3.7 2.3 2.2 2.1 (Please read first Refill the notes on the back (This page) Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs as shown in Table 1. Regarding the medicament volatilization device of the present invention, it is believed that the volatilization amount of the medicament is stable over a long period of 30 days and maintains a high degree of insecticidal efficacy. That is, the use of the medicine cartridge provided with Example 1 hardly changes the amount of time with time. After 30 days, the insecticidal effect is almost constant, and it is considered to have excellent stability over time. As shown in Table 2, in the comparative example 1, the medicine box containing the immersion structure of the medicine impregnated body and the wings were formed separately. Compared with the medicine box using the medicine box of Example 1 as a medicine volatilization device, the volatilization effect was improved. In the above, this paper size is applicable to Chinese National Standard (CNS) A4 specification (210X297mm) -27- 534796 A7 B7 V. Description of the invention (4 The former is significantly worse. (Please read the precautions on the back before filling this page ) Effects of the Invention With regard to the medicament volatilization device of the present invention, since the medicament volatilization of the medicament-impregnated body is promoted by using airflow without heating, there is no risk of burns during use and it can be stable for a long time. To play loose a certain amount of the drug, as no longer able to maintain the past through the excellent insecticidal effect. In addition, it has excellent safety and usability, and is extremely useful for controlling harmful insects such as mosquitoes, flies, and unpleasant pests such as maggots, roundworms, small roundworms, and catfish worms, especially for controlling mosquitoes. In addition, the medicament scattering device of the present invention operates on a battery, is small and lightweight, and can be used indoors or outdoors. It is very helpful to prevent the removal of sanitary or unpleasant pests, such as when traveling indoors or in camping tents. Printed by the Consumers' Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs on the medicine dispersing device of the present invention, the medicine cartridge used in the medicine dispersing body is integrally formed with the hollow structure of the impregnated body and the wings, which can generate a stronger airflow and the airflow Contact with the drug impregnated body without weakening, and improve the volatility efficiency. Moreover, it is not necessary to manufacture the assembled wings and the hollow structure separately, and the troublesome operation that must be correctly joined when the combination is omitted can be omitted from the production point of view, which is very advantageous. The medicine box in the present invention is made of plastic resin, especially polyester resin (such as polyethylene terephthalate whose viscosity is limited to 0. 7 d 1 / g or less), and it can be used without loss for a long time. Effectively release the pharmaceutical ingredients, and there is almost no loss of the pharmaceuticals during long-term storage, which is extremely useful. This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) -28- 534796 A7 B7 V. Description of the invention (2 ^ (Please read the precautions on the back before filling out this page) and have the remaining amount display function or the remaining amount display function of the battery 'can accurately and clearly grasp the life or remaining amount of the medicine box or battery, is Practical. Brief description of the drawing. Fig. 1 is a perspective view of the medicament volatilization device of the present invention. Fig. 2 is a front view of the medicament volatilization device of the present invention. Fig. 3 is a side view of the medicament volatilization device of the present invention. Fig. 4 is a schematic view showing a cross-section taken along the line AA 'in Fig. 2. Fig. 5 is a perspective view above a medicine cassette in the medicine dispensing device of the present invention. Elixir An oblique view below the medicine box placed in the center. Fig. 7 is a perspective view showing the disassembled state of the medicine box in the medicine dispersing device of the present invention. Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs Fig. 8 is about the present invention An oblique view of the remaining amount display function or the remaining amount display function of the battery of the medicine dispersing device. Fig. 9 is a sectional view of the medicine dispersing device shown in Fig. 8. Fig. 10 is the medicine dispersing device shown in Fig. 9 Electronic circuit diagram. Component comparison table 1 Device body 2 Pharmacy box The paper size is applicable to China National Standard (CNS) A4 (210X297 mm) ^ — -29- 534796 A7 B7
五、發明説明（A 經濟部智慧財產局員工消費合作社印製 3 藥 劑 含 浸 體 4 馬 達 5 電 池 6 蓋 子 7 藥 劑 殘 量 液 晶 顯 示 器 8 電 池 殘 里 液 晶 顯 示 器 9 重 新 設 定 按 鍵 1 1 凹 形 部 1 2 電 源 開 關 1 3 開 □ 部 1 4 吊 1 5 吊 下 部 1 6 馬 達 連 接 部 2 1 中 空 構 造 體 2 2 外 圓 面 開 □ 部 2 3 內 圓 面 開 □ 部 2 4 回 轉 支 持 軸 2 5 軸 心 部 2 6 翼 部 2 7 軸 聿虽 部 2 8 本 體 部 份 2 9 溝 槽 蓋 3 〇 C Ρ U 用 電 源 電 路 基盤 3 1 馬 達 用 電 線 電 路 基 盤 (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） 30- 534796 A7 B7 五、發明説明（4 3 2 磁氣帶 3 3 磁氣官能掃描器 3 4 A C轉接器 3 5 電線 3 6 連接器 37 直流電源 6 1 開口部 6 2 補強部 6 3 開關按鍵。 (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） -31 -V. Description of the invention (A Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs 3 Pharmaceutical impregnated body 4 Motor 5 Battery 6 Cap 7 Residual liquid crystal display 8 Battery residual liquid crystal display 9 Reset button 1 1 Recessed part 1 2 Power supply Switch 1 3 Opening part 1 4 Hanging 1 5 Hanging lower part 1 6 Motor connection part 2 1 Hollow structure 2 2 Outer surface open part 2 3 Inner surface open part 2 4 Rotary support shaft 2 5 Shaft center part 2 6 Wing part 2 7 Shaft part 2 8 Body part 2 9 Groove cover 3 〇C 普 U Power circuit base 3 1 Motor wire circuit base (Please read the precautions on the back before filling this page) This paper Standards apply to Chinese National Standard (CNS) A4 specifications (210X297 mm) 30- 534796 A7 B7 V. Description of the invention (4 3 2 Magnetic tape 3 3 Magnetic functional scanner 3 4 AC adapter 3 5 Wire 3 6 Connection Device 37 DC power supply 6 1 Opening section 6 2 Reinforcing section 6 3 Switch button. (Please read the precautions on the back before filling this page) Printed on the paper standard of the China National Standards (CNS) A4 (210X297) %) -31-